Synergic effect of NADP+ on the antitumor properties of low doses of 9 OH-ellipticine towards Walker cells.
D000470:Alkaloids / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004611:Ellipticines / Q000627:therapeutic use*; D009249:NADP / Q000627:therapeutic use*; D051381:Rats; D011920:Rats, Inbred WF
D000470:Alkaloids; D000970:Antineoplastic Agents; D004611:Ellipticines; D009249:NADP; C008009:9-hydroxyellipticine